Cell Line Genetics is the leading provider of stem cell characterization and multispecies quality assurance services and products specifically designed to ensure the genetic integrity and authentication of adult and pluripotent stem cell lines.
As a leader in the Stem Cell and Regenerative Medicine field CLG has the track record and technical expertise to meet the demanding needs of the leading universities and research institutes, as well as biotechnology and pharmaceutical companies worldwide.
Cell Line Genetics is an independent and privately owned company, not affiliated with any academic institutions, research institutes, or government-funded laboratories. Confidentiality is guaranteed.
Latest News:
Cell Line Genetics Inc. is a Proud Sponsor and Exhibitor of the 4th Annual Maryland Stem Cell Research Symposium
The 4th Annual Maryland Stem Cell Research Symposium will be held on September 6th at Townson University and will profile Maryland’s leading stem cell investigators and state funded projects. To date, the Maryland Stem Cell Research Fund has allocated over $78.8 million towards 218 stem cell research grants in just five years. Cell Line Genetics commends the Maryland Stem Cell Research Fund for their leadership and commitment to the field. We encourage you to join us for this special event! Learn More
Posted: 09/21/2011
Cell Line Genetics and Ambry Genetics Announce Exclusive Global Agreement For Sales of Ambry Genetics’ StemArray™ and Related Services
MADISON, Wisc., New York, NY and ALISO VIEJO, Calif. – June 15, 2011 - Cell Line Genetics, Inc., a leader in Stem Cell Quality Assurance services and products, and Ambry Genetics, a global leader in genetic services with a focus on clinical diagnostics and genomics, announced today an exclusive agreement under which Cell Line Genetics will sell the Ambry StemArray™ aCGH (array Comparative Genomic Hybridization) product and related services to its current customers as well as other companies and research institutions. Both companies believe this partnership will dramatically expand the availability of the Ambry StemArray and hasten its adoption in the stem cell and regenerative medicine market globally. Learn More
Posted: 06/15/2011
Cell Line Genetics Marks 7,500 Quality Assurance Cases in the Field of Stem Cell Research & Regenerative Medicine
MADISON, Wis. & NEW YORK--(BUSINESS WIRE)--Cell Line Genetics, Inc. (“CLG”), a leader in Stem Cell Quality Assurance (“QA”) services and products, announced today that it has performed QA services on over 7,500 stem cell samples. The company concurrently announced significant additions to both its management and scientific teams: Robert Margolin has been appointed to Director of Marketing, and the company expanded its research and product development team in Madison, Wisconsin. Learn More
Posted: 06/08/2011
Cell Line Genetics Honored as One of the 2011 “Wisconsin Companies to Watch”
MADISON, Wis. & NEW YORK--(BUSINESS WIRE)--Cell Line Genetics, LLC (“CLG”), a leader in Stem Cell Quality Assurance (“QA”) services and products, has been recognized as one of the thirty-three 2011 “Wisconsin Companies to Watch,” an awards program presented by the Wisconsin Entrepreneurs’ Network (WEN) with support from the Wisconsin SBDC Network and the Division of Entrepreneurship and Economic Development (DEED) at the University of Wisconsin-Extension in association with the Edward Lowe Foundation. Learn More
Posted: 05/20/2011